GENZYME APPROACHING 100 PATIENTS ON CEREDASE: $ 20,000-$ 60,000 PER YEAR GAUCHER DISEASE DRUG AVAILABLE FOR WIDER USE AND REIMBURSEMENT AFTER FDA OKAY

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".